Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Phase III results with Metvix PDT for primary BCC reported as positive

Jan. 10, 2001

Novogen begins second phase I trial of anticancer agent in Australia

Jan. 9, 2001

Phytopharm reports promising clinical trial results for P-54 in colorectal cancer

Jan. 9, 2001

Matrix completes NDA filing for IntraDose injectable gel

Jan. 9, 2001

Wide series of CDK/cyclin inhibitors developed at Pharmacia

Jan. 9, 2001

FDA issues nonapprovable letter for Atragen; company plans to continue development

Jan. 9, 2001

Elan prepares launch of Myocet in Europe

Jan. 8, 2001

Anti-EGF MAb produces clinical, biochemical improvement in patient with Menetrier's disease

Jan. 8, 2001

Topically applied CDK2 inhibitor prevents chemotherapy-induced hair loss

Jan. 8, 2001

NeoOncoRx to acquire worldwide rights to novel class of anticancer agents

Jan. 5, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...